Technology areas: Biotechnology & Pharmaceuticals • Computing & Software
3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 9 patents granted in the last 365 days
Noblis Inc.’s portfolio concerns Biotechnology & Pharmaceuticals and has 3 pending office actions. The matters are assigned to 3 distinct examiners and 3 distinct art units, showing distribution across separate examination channels. Counsel should manage each matter independently and look for recurring technical or claim issues without assuming that the same response will apply across the portfolio.
CHANNAVAJJALA, SRIRAMA T is the busiest examiner, with 1 pending matter. The other pending matters are handled by different examiners and art units. A practical strategy is to coordinate overall claim objectives and terminology while tailoring arguments, evidence, and amendments to each biotechnology and pharmaceutical examination record.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 2 (67%) |
| No statute on record | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CHANNAVAJJALA, SRIRAMA T | 1 | 74.6% | +32.3% |
| FONSECA LOPEZ, FRANCINI ALVARENGA | 1 | 28.6% | +30.0% |
| ZEMAN, MARY K | 1 | 58.9% | +34.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18414076 | SYSTEMS AND METHODS FOR EVALUATING TRAINED MODELS | CHANNAVAJJALA, SRIRAMA T | — |
| 17937866 | SYSTEMS AND METHODS FOR CONFIGURING AND DEPLOYING A PORTABLE FIELD-DEPLOYABLE BIOSURVEILLANCE KIT | FONSECA LOPEZ, FRANCINI ALVARENGA | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18414076 | SYSTEMS AND METHODS FOR EVALUATING TRAINED MODELS | CHANNAVAJJALA, SRIRAMA T | — |
| 17937866 | SYSTEMS AND METHODS FOR CONFIGURING AND DEPLOYING A PORTABLE FIELD-DEPLOYABLE BIOSURVEILLANCE KIT | FONSECA LOPEZ, FRANCINI ALVARENGA | — |
| 17572170 | PRIMER DESIGN USING INDEXED GENOMIC INFORMATION | ZEMAN, MARY K | — |
| Art Unit | Apps |
|---|---|
| 2154 | 1 |
| 1685 | 1 |
| 1686 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18414076 | SYSTEMS AND METHODS FOR EVALUATING TRAINED MODELS | CHANNAVAJJALA, SRIRAMA T | 2154 | §101§103§112 | Non-Final OA | — | Pending | Jan 16, 2024 |
| 17937866 | SYSTEMS AND METHODS FOR CONFIGURING AND DEPLOYING A PORTABLE FIELD-DEPLOYABLE BIOSURVEILLANCE KIT | FONSECA LOPEZ, FRANCINI ALVARENGA | 1685 | §101§103§112 | Non-Final OA | — | Pending | Oct 04, 2022 |
| 17572170 | PRIMER DESIGN USING INDEXED GENOMIC INFORMATION | ZEMAN, MARY K | 1686 | Other | Final Rejection | — | Pending | Jan 10, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialNoblis Inc. has 3 pending office actions as of October 2026, spread across 3 art units and 3 examiners.
Srirama T Channavajjala has the most, with 1 of Noblis Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
